Target Name: A1BG
NCBI ID: G1
Other Name(s): GAB | A1BG_HUMAN | Alpha-1B-glycoprotein | alpha-1-B glycoprotein | Alpha-1-B glycoprotein | HEL-S-163pA | ABG | A1B | HYST2477 | DKFZp686F0970 | epididymis secretory sperm binding protein Li 163pA

A1BG: A drug target and biomarker with unique insulin interactions

A1BG is a drug target and a biomarker that is expressed in various tissues of the human body. It is a type of carbohydrate derived from the glucose molecule that has a sulfur atom attached to the 2-position carbon.

A1BG has been shown to have various biological functions, including its role in cellular signaling, DNA replication, and neurotransmission. Its role in cellular signaling is related to its ability to interact with various signaling molecules, including insulin, growth factors, and neurotransmitters.

One of the unique features of A1BG is its ability to interact with insulin. Insulin is a hormone that plays a crucial role in regulating blood sugar levels, and its interactions with A1BG have been shown to regulate glucose uptake and storage in the body. This interaction between A1BG and insulin suggests that A1BG may be a potential target for drugs that treat type 2 diabetes.

In addition to its role in cellular signaling, A1BG has also been shown to be involved in the regulation of DNA replication and neurotransmission. Its ability to interact with DNA has led to the hypothesis that A1BG may be a potential drug target for treating cancer.

A1BG has also been shown to be involved in the regulation of neurotransmission, which is the process by which nerve cells communicate with each other. This interaction between A1BG and neurotransmitters suggests that A1BG may be a potential target for drugs that treat neurodegenerative diseases.

In conclusion, A1BG is a drug target and biomarker that has been shown to have various biological functions, including its role in cellular signaling, DNA replication, and neurotransmission. Its unique ability to interact with insulin and other signaling molecules suggests that A1BG may be a potential target for drugs that treat type 2 diabetes, cancer, and neurodegenerative diseases. Further research is needed to fully understand the role of A1BG in the treatment of these diseases.

Protein Name: Alpha-1-B Glycoprotein

More Common Targets

A1BG-AS1 | A1CF | A2M | A2M-AS1 | A2ML1 | A2MP1 | A3GALT2 | A4GALT | A4GNT | AAAS | AACS | AACSP1 | AADAC | AADACL2 | AADACL2-AS1 | AADACL3 | AADACL4 | AADACP1 | AADAT | AAGAB | AAK1 | AAMDC | AAMP | AANAT | AAR2 | AARD | AARS1 | AARS2 | AARSD1 | AASDH | AASDHPPT | AASS | AATBC | AATF | AATK | ABALON | ABAT | ABCA1 | ABCA10 | ABCA11P | ABCA12 | ABCA13 | ABCA17P | ABCA2 | ABCA3 | ABCA4 | ABCA5 | ABCA6 | ABCA7 | ABCA8 | ABCA9 | ABCB1 | ABCB10 | ABCB11 | ABCB4 | ABCB5 | ABCB6 | ABCB7 | ABCB8 | ABCB9 | ABCC1 | ABCC10 | ABCC11 | ABCC12 | ABCC13 | ABCC2 | ABCC3 | ABCC4 | ABCC5 | ABCC6 | ABCC6P1 | ABCC6P2 | ABCC8 | ABCC9 | ABCD1 | ABCD2 | ABCD3 | ABCD4 | ABCE1 | ABCF1 | ABCF1-DT | ABCF2 | ABCF3 | ABCG1 | ABCG2 | ABCG4 | ABCG5 | ABCG8 | ABHD1 | ABHD10 | ABHD11 | ABHD11-AS1 | ABHD12 | ABHD12B | ABHD13 | ABHD14A | ABHD14B | ABHD15 | ABHD16A | ABHD16B